Versor Investments’s Trillium Therapeutics Inc. TRIL Stock Holding History

Versor Investments’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,923,455	Closed	-$33.8M	–	697
2021 Q3	$33.8M	Buy	+1,923,455	New	+$22.5M	1.04%	40

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Versor Investments's TRIL Position: Q4 2021 in Review

Versor Investments sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 1,923,455 shares — an estimated $33.8M sold.

Versor Investments first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $33.8M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Versor Investments reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Versor Investments sold 1,923,455 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $33.8M.
Versor Investments first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
Versor Investments's Trillium Therapeutics Inc. position peaked at $33.8M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Versor Investments's 13F filing for Q4 2021, filed 8 Feb 2022.